Biotech whizz who changed the world
“In just over a decade, Moderna’s market value has shot to nearly $115bn on the back of a single commercial product”
If Stéphane Bancel ever questioned his ability to move markets, he got his answer last week. The Moderna CEO’s observation that existing vaccines will be less effective at tackling Omicron than earlier strains of Covid-19 rattled investors sufficiently
